| scholarly article | Q13442814 |
| P50 | author | Karen Ashe | Q6369493 |
| Carrie M Wilmot | Q42119431 | ||
| P2093 | author name string | Peng Liu | |
| Wei Qiang | |||
| Joanna L Jankowsky | |||
| Marianne K O Grant | |||
| Kathleen R Zahs | |||
| Colleen L Forster | |||
| Samantha L Shapiro | |||
| Miranda N Reed | |||
| James P Cleary | |||
| Angie C A Chiang | |||
| Linda A Kotilinek | |||
| John H Reichl | |||
| P2860 | cites work | Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease | Q21144713 |
| Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice | Q22242267 | ||
| Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity | Q43196382 | ||
| Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. | Q46380915 | ||
| Learning decreases A beta*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice. | Q46765311 | ||
| Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans | Q48381176 | ||
| Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab | Q48852013 | ||
| Grape seed polyphenolic extract specifically decreases aβ*56 in the brains of Tg2576 mice | Q49067502 | ||
| Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. | Q51811574 | ||
| Acquisition of conditional associations and operant delayed spatial response alternation: effects of lesions in the medial prefrontal cortex. | Q52069538 | ||
| Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. | Q53274559 | ||
| Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory | Q24645499 | ||
| Neuropathological alterations in Alzheimer disease | Q27003314 | ||
| Out-of-register -sheets suggest a pathway to toxic amyloid aggregates | Q27675366 | ||
| Antiparallel -sheet architecture in Iowa-mutant -amyloid fibrils | Q27677945 | ||
| Atomic View of a Toxic Amyloid Small Oligomer | Q27677948 | ||
| Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue | Q27679935 | ||
| Modeling an in-register, parallel "iowa" aβ fibril structure using solid-state NMR data from labeled samples with rosetta | Q27697071 | ||
| A specific amyloid-beta protein assembly in the brain impairs memory | Q28854597 | ||
| Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques | Q29028192 | ||
| Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment | Q29547294 | ||
| Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis | Q29547501 | ||
| APP processing and synaptic function | Q29615873 | ||
| Structural classification of toxic amyloid oligomers | Q30484255 | ||
| Cognitive effects of cell-derived and synthetically derived Aβ oligomers | Q30495253 | ||
| Brain amyloid-β oligomers in ageing and Alzheimer's disease | Q30539133 | ||
| Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. | Q31840691 | ||
| The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. | Q33292445 | ||
| Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life | Q33292558 | ||
| Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation | Q33673470 | ||
| Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease | Q33707872 | ||
| Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism | Q34346440 | ||
| Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease. | Q34656208 | ||
| Amyloid-β annular protofibrils evade fibrillar fate in Alzheimer disease brain | Q35063033 | ||
| Solid-state NMR studies of amyloid fibril structure | Q35327629 | ||
| Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile | Q35577702 | ||
| Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers | Q36178075 | ||
| Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease | Q36855702 | ||
| Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology | Q37043088 | ||
| Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. | Q37180168 | ||
| A single dose of passive immunotherapy has extended benefits on synapses and neurites in an Alzheimer's disease mouse model | Q37259695 | ||
| Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance | Q37352312 | ||
| Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains. | Q37432185 | ||
| 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study | Q37699953 | ||
| The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes | Q37979641 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 1760-1771 | |
| P577 | publication date | 2015-06-04 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration | |
| P478 | volume | 11 |
| Q37134269 | A Decentralized Approach to the Formulation of Hypotheses: A Hierarchical Structural Model for a Prion Self-Assembled System |
| Q91723176 | A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer's Disease |
| Q46341580 | A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid-β oligomers |
| Q37724402 | Alzheimer's Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station |
| Q26771532 | Amyloid-β Receptors: The Good, the Bad, and the Prion Protein |
| Q46240783 | Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies. |
| Q45953477 | Atomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (ALS). |
| Q92107333 | Aβ oligomers trigger and accelerate Aβ seeding |
| Q48137001 | Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis |
| Q92816520 | Aβ(M1-40) and Wild-Type Aβ40 Self-Assemble into Oligomers with Distinct Quaternary Structures |
| Q56342045 | Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons |
| Q41074727 | Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases |
| Q46316131 | Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation |
| Q53416393 | Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice. |
| Q42683481 | Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology. |
| Q88450906 | Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer's disease brain |
| Q46238269 | Discrete pools of oligomeric amyloid-β track with spatial learning deficits in a mouse model of Alzheimer amyloidosis. |
| Q36894417 | Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes |
| Q41871137 | Ganglioside-Dependent Neural Stem Cell Proliferation in Alzheimer's Disease Model Mice |
| Q46405748 | Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity. |
| Q57039690 | Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden |
| Q28066391 | Molecular Structure of Aggregated Amyloid-β: Insights from Solid-State Nuclear Magnetic Resonance |
| Q46024871 | Nanoscale Dynamics of Amyloid β-42 Oligomers As Revealed by High-Speed Atomic Force Microscopy. |
| Q38796950 | Network abnormalities and interneuron dysfunction in Alzheimer disease |
| Q46538110 | Non-Fibrillar Oligomeric Amyloid-β within Synapses |
| Q38619618 | Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease. |
| Q38794219 | Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases. |
| Q92608280 | Oral Immunization with Soybean Storage Protein Containing Amyloid-β 4-10 Prevents Spatial Learning Decline |
| Q57273364 | Origin of metastable oligomers and their effects on amyloid fibril self-assembly |
| Q28076932 | PMEL Amyloid Fibril Formation: The Bright Steps of Pigmentation |
| Q38959054 | Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity. |
| Q38960046 | Potential mechanisms and implications for the formation of tau oligomeric strains |
| Q36109803 | Pre-amyloid oligomers of the proteotoxic RepA-WH1 prionoid assemble at the bacterial nucleoid |
| Q41702344 | Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions. |
| Q39022241 | Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases. |
| Q37610732 | Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice |
| Q58027500 | Rodent models for Alzheimer disease |
| Q46362244 | Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits |
| Q46523542 | Self-assembly of the full-length amyloid Aβ42 protein in dimers |
| Q58797396 | Shear-Induced Amyloid Formation in the Brain: III. The Roles of Shear Energy and Seeding in a Proposed Shear Model |
| Q47785630 | Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload |
| Q38777380 | Study of Exosomes Shed New Light on Physiology of Amyloidogenesis |
| Q54977832 | The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade. |
| Q26747107 | The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy |
| Q46368794 | The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation. |
| Q48340201 | Toward peptide-based inhibitors as therapies for Parkinson's disease. |
| Q36871202 | What amyloid ligands can tell us about molecular polymorphism and disease |
| Q36797995 | X-ray Crystallographic Structures of a Trimer, Dodecamer, and Annular Pore Formed by an Aβ17-36 β-Hairpin |
Search more.